Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-15 12:50 pm Purchase |
2021-10-15 | 13D | Enzo Biochem, Inc. ENZB |
James G. Wolf | 3,262,500 6.730% |
621,800 (+23.55%) |
Filing History |
| 2021-10-28 4:39 pm Unchanged |
2021-10-27 | 13D | Enzo Biochem, Inc. ENZB |
Harbert Discovery Fund, LP | 5,175,913 10.680% |
0 (Unchanged) |
Filing History |
| 2021-10-22 12:05 pm Purchase |
2021-10-20 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 3,615,000 7.500% |
505,000 (+16.24%) |
Filing History |
| 2021-10-06 09:52 am Purchase |
2021-10-01 | 13D | Enzo Biochem, Inc. ENZB |
Radoff Bradley Louis | 3,110,000 6.400% |
3,110,000 (New Position) |
Filing History |
| 2021-10-01 12:38 pm Purchase |
2021-09-30 | 13D | Enzo Biochem, Inc. ENZB |
James G. Wolf | 2,640,700 5.400% |
79,400 (+3.10%) |
Filing History |
| 2021-09-30 06:12 am Unchanged |
2021-09-29 | 13D | Enzo Biochem, Inc. ENZB |
Roumell Asset Management LLC | 2,886,771 6.000% |
0 (Unchanged) |
Filing History |
| 2021-08-20 2:39 pm Purchase |
2021-08-10 | 13G | Enzo Biochem, Inc. ENZB |
James G. Wolf | 2,561,300 5.300% |
2,561,300 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Enzo Biochem, Inc. ENZB |
BlackRock Inc. BLK |
1,550,385 3.200% |
-2,204,631 (-58.71%) |
Filing History |
| 2021-05-05 06:45 am Purchase |
2021-05-05 | 13D | Enzo Biochem, Inc. ENZB |
Roumell Asset Management LLC | 2,886,771 6.000% |
125,542 (+4.55%) |
Filing History |
| 2021-03-17 5:28 pm Sale |
2021-03-16 | 13D | Enzo Biochem, Inc. ENZB |
Harbert Discovery Fund, LP | 5,175,913 10.730% |
-444,768 (-7.91%) |
Filing History |
| 2021-02-26 4:12 pm Unchanged |
2021-02-26 | 13D | Enzo Biochem, Inc. ENZB |
Harbert Discovery Fund, LP | 5,620,681 11.740% |
0 (Unchanged) |
Filing History |
| 2021-02-11 07:25 am Purchase |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
RENAISSANCE TECHNOLOGIES LLC | 3,556,223 7.430% |
202,415 (+6.04%) |
Filing History |
| 2021-02-10 10:52 am Purchase |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
The Vanguard Group | 2,397,798 5.010% |
2,397,798 (New Position) |
Filing History |
| 2021-02-04 11:19 am Sale |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
Wellington Management Group LLP | 0 0.000% |
-3,576,530 (Position Closed) |
Filing History |
| 2021-02-03 09:29 am Sale |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
Wellington Trust Company, NA | 0 0.000% |
-3,389,548 (Position Closed) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
BlackRock Inc. BLK |
3,755,016 7.800% |
56,404 (+1.53%) |
Filing History |
| 2021-01-15 3:42 pm Sale |
2020-12-31 | 13G | Enzo Biochem, Inc. ENZB |
Evermore Global Advisors LLC | 2,605,607 5.400% |
-1,402,244 (-34.99%) |
Filing History |
| 2021-01-15 08:30 am Sale |
2021-01-14 | 13D | Enzo Biochem, Inc. ENZB |
Roumell Asset Management LLC | 2,761,229 5.800% |
-8,250 (-0.30%) |
Filing History |
| 2021-01-05 3:02 pm Unchanged |
2021-01-05 | 13D | Enzo Biochem, Inc. ENZB |
Roumell Asset Management LLC | 2,769,479 5.800% |
0 (Unchanged) |
Filing History |
| 2021-01-04 5:14 pm Unchanged |
2021-01-04 | 13D | Enzo Biochem, Inc. ENZB |
Harbert Discovery Fund, LP | 5,620,681 11.740% |
0 (Unchanged) |
Filing History |